Cited by 7Advanced Proteomics Techniques and ApplicationsOvarian cancer diagnosis and treatmentMass Spectrometry Techniques and Applications

Deciphering the ghost proteome in ovarian cancer cells by deep proteogenomic characterization

Open access
Garcia-del Rio, Diego Fernando, Derhourhi, Mehdi, Bonnefond, Amelie, Leblanc, Sébastien, Guilloy, Noé, Roucou, Xavier, Eyckerman, Sven, Gevaert, Kris +2 more·2024·Cell Death & Disease

Published version of a preprint

Abstract

Proteogenomics is becoming a powerful tool in personalized medicine by linking genomics, transcriptomics and mass spectrometry (MS)-based proteomics. Due to increasing evidence of alternative open reading frame-encoded proteins (AltProts), proteogenomics has a high potential to unravel the characteristics, variants, expression levels of the alternative proteome, in addition to already annotated proteins (RefProts). To obtain a broader view of the proteome of ovarian cancer cells compared to ovarian epithelial cells, cell-specific total RNA-sequencing profiles and customized protein databases were generated. In total, 128 RefProts and 30 AltProts were identified exclusively in SKOV-3 and PEO-4 cells. Among them, an AltProt variant of IP_715944, translated from DHX8 , was found mutated (p.Leu44Pro). We show high variation in protein expression levels of RefProts and AltProts in different subcellular compartments. The presence of 117 RefProt and two AltProt variants was described, along with their possible implications in the different physiological/pathological characteristics. To identify the possible involvement of AltProts in cellular processes, cross-linking-MS (XL-MS) was performed in each cell line to identify AltProt-RefProt interactions. This approach revealed an interaction between POLD3 and the AltProt IP_183088, which after molecular docking, was placed between POLD3-POLD2 binding sites, highlighting its possibility of the involvement in DNA replication and repair.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-024-07046-1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Garcia-del Rio, D. F., Derhourhi, M., Bonnefond, A., Leblanc, S., Guilloy, N., Roucou, X., Eyckerman, S., Gevaert, K., Salzet, M., & Cardon, T.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Université de Sherbrooke (CA)
  • Ghent University (BE)
  • Inserm (FR)
Corresponding author
  • Salzet, Michel
  • Cardon, Tristan
Venue
Cell Death & Disease
Published
2024-09-30
Volume
15
Issue
9
Pages
712-712
ISSN
2041-4889 (ISSN-L)
OpenAlex
W4402983075
Cited by
7
References
3
Citations by year
2026: 2 · 2025: 5
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • LillOA (Université de Lille (University Of Lille)) (submittedVersion)
Funders
  • Université de Lille
  • Institut National de la Santé et de la Recherche Médicale
  • Fonds Wetenschappelijk Onderzoek (G008018N)
  • Vlaamse regering
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
ovarian cancer, proteogenomics, POLD3, protein-protein interaction, cross-linking mass spectrometry, SKOV3 cells, DNA replication and repair
MeSH terms
Proteogenomics, Female, Humans, Ovarian Neoplasms, Open Reading Frames, Proteome, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review